Alembic Pharma gets tentative USFDA nod for generic Rivaroxaban tablets

Rivaroxaban tablets are indicated for multiple conditions, including reduction of risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation; treatment of deep vein thrombosis (DVT) and treatment of pulmonary embolism (PE).

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/37Qdc2Z
via IFTTT